LIMK1 and prostate carcinoma: LIMK1 overexpression could increase the invasiveness of breast and prostate cancer cells both in vitro and in vivo, and knockdown of LIMK1 could diminish invasion of breast carcinoma and prostate carcinoma cells [46,47].